製品名:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

IUPAC Name:4-[(1-cyano-1-methylethyl)amino]-2-fluoro-N-methylbenzamide

CAS番号:915087-32-0
分子式:C12H14FN3O
純度:95%+
カタログ番号:CM329948
分子量:235.26

包装単位 有効在庫 価格(USD) 数量
CM329948-100mg in stock ȖȯȖ
CM329948-250mg in stock ŪȯȖ
CM329948-1g in stock ȯǫŞ
CM329948-5g 1-2 Weeks ȖǑȅȖ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:915087-32-0
分子式:C12H14FN3O
融点:-
SMILESコード:O=C(NC)C1=CC=C(NC(C)(C#N)C)C=C1F
密度:
カタログ番号:CM329948
分子量:235.26
沸点:
MDL番号:
保管方法:

Column Infos

Enzalutamide
Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.